Phreesia, Inc. $PHR Stake Lessened by Dimensional Fund Advisors LP

Key Points

• Dimensional Fund Advisors reduced its Phreesia stake by 22.9% in the first quarter, selling 143,563 shares and retaining 484,717 shares valued at approximately $4.1 million. Institutional investors collectively own 92.1% of the company.
• Phreesia reported quarterly EPS of $0.05, beating estimates by $0.03, while revenue rose 12.9% year over year to $130.94 million. Shares opened at $12.21, with a 52-week range of $7.77 to $32.76.
• Analyst sentiment is mixed, with nine Buy, nine Hold and one Sell rating; the stock has an overall “Hold” consensus and an average price target of $16.65.

Dimensional Fund Advisors LP lessened its holdings in Phreesia, Inc. (NYSE:PHR - Free Report) by 22.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 484,717 shares of the company's stock after selling 143,563 shares during the period. Dimensional Fund Advisors LP owned about 0.80% of Phreesia worth $4,071,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Vanguard Group Inc. raised its position in Phreesia by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 5,744,326 shares of the company's stock valued at $97,194,000 after buying an additional 39,540 shares during the period. Granahan Investment Management LLC boosted its position in Phreesia by 73.8% during the 4th quarter. Granahan Investment Management LLC now owns 2,399,613 shares of the company's stock worth $40,601,000 after acquiring an additional 1,018,987 shares during the period. Franklin Resources Inc. boosted its position in Phreesia by 28.8% during the 4th quarter. Franklin Resources Inc. now owns 2,000,082 shares of the company's stock worth $33,841,000 after acquiring an additional 446,890 shares during the period. Nuveen LLC grew its stake in Phreesia by 12.7% during the 4th quarter. Nuveen LLC now owns 1,875,725 shares of the company's stock valued at $31,737,000 after acquiring an additional 211,262 shares in the last quarter. Finally, Millennium Management LLC grew its stake in Phreesia by 47.6% during the 4th quarter. Millennium Management LLC now owns 1,571,055 shares of the company's stock valued at $26,582,000 after acquiring an additional 506,923 shares in the last quarter. Hedge funds and other institutional investors own 92.10% of the company's stock.

Phreesia Stock Performance

Shares of PHR stock opened at $12.21 on Thursday. Phreesia, Inc. has a fifty-two week low of $7.77 and a fifty-two week high of $32.76. The stock's 50-day moving average is $10.41 and its two-hundred day moving average is $10.64. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.76 and a quick ratio of 1.76. The firm has a market cap of $754.70 million, a P/E ratio of 81.40 and a beta of 0.85.

Phreesia (NYSE:PHR - Get Free Report) last announced its quarterly earnings results on Wednesday, May 27th. The company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.02 by $0.03. The business had revenue of $130.94 million during the quarter, compared to analyst estimates of $130.08 million. Phreesia had a return on equity of 5.13% and a net margin of 1.85%.The firm's revenue was up 12.9% on a year-over-year basis. During the same period in the previous year, the company earned ($0.07) EPS. Analysts predict that Phreesia, Inc. will post 0.39 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on PHR shares. Weiss Ratings raised shares of Phreesia from a "sell (d)" rating to a "sell (d+)" rating in a research report on Monday, July 20th. Citigroup restated a "market perform" rating on shares of Phreesia in a report on Friday, May 29th. Wall Street Zen raised shares of Phreesia from a "hold" rating to a "buy" rating in a research report on Saturday, May 30th. Truist Financial upped their price objective on shares of Phreesia from $11.00 to $12.00 and gave the company a "hold" rating in a research note on Thursday, May 28th. Finally, Canaccord Genuity Group cut their target price on shares of Phreesia from $22.00 to $16.00 and set a "buy" rating for the company in a research report on Thursday, May 28th. Nine analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Phreesia presently has an average rating of "Hold" and a consensus price target of $16.65.

Phreesia Profile

Phreesia, Inc NYSE: PHR is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company's cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.

Want to see what other hedge funds are holding PHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phreesia, Inc. (NYSE:PHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source